Woo T L, Francis I C, Wilcsek G A, Coroneo M T, McNab A A, Sullivan T J
Ocular Plastics Unit, Prince of Wales Hospital. University of NSW, Randwick, Australia.
Ophthalmology. 2001 Sep;108(9):1535-43. doi: 10.1016/s0161-6420(01)00655-8.
To report a retrospective case series of 29 Australian and New Zealand patients with orbital and adnexal Wegener's granulomatosis (WG).
Retrospective case series.
Twenty-nine cases of orbital and adnexal WG were identified.
A number of oculoplastic surgeons and other clinicians in Australia and New Zealand was asked about their experience with orbital and adnexal WG. Clinical data regarding these cases were conveyed by means of a questionnaire. Cases of ophthalmic WG without features of orbital or adnexal disease were excluded.
Data obtained from the questionnaire includes age, gender, limited or generalized disease, antineutrophil cytoplasmic antibody (ANCA) status, symptoms and signs: nasolacrimal obstruction, sinusitis, fistula/orbital bone erosion, orbital mass/proptosis, extraocular muscle/diplopia, visual acuity reduction caused by optic nerve compression, orbital pain, lid edema/erythema, biopsy status, and treatment status.
Twenty-nine patients with orbital and adnexal WG were identified and described. Symptoms included awareness of an orbital mass, epiphora, orbital pain and diplopia. Signs included an orbital mass or proptosis (69%), nasolacrimal duct obstruction (52%), limited ocular rotations (52%), lid erythema and edema (31%), bony destruction (21%), and reduced visual acuity (17%). Two patients had a persistent nasolacrimocanthal fistula. Cytoplasmic pattern antineutrophil cytoplasmic antibodies (c-ANCA) were present in 52% of patients, and in 9 of 10 patients with generalized disease. However, c-ANCA was positive in only 32% (6 of 19) of patients with limited WG. Perinuclear pattern antineutrophil cytoplasmic antibodies (p-ANCA) was positive in 10% of cases.
To diagnose and treat ophthalmic WG effectively, the clinician must be aware of its protean orbital and adnexal manifestations. WG may occur with or without systemic involvement, and c-ANCA was negative in approximately half our cases. Our cases also demonstrated two orbital fistulae, an observation previously believed to be rare.
报告29例澳大利亚和新西兰眼眶及附件韦格纳肉芽肿(WG)患者的回顾性病例系列。
回顾性病例系列。
确定了29例眼眶及附件WG病例。
向澳大利亚和新西兰的多位眼整形外科医生及其他临床医生询问他们处理眼眶及附件WG的经验。这些病例的临床数据通过问卷进行传递。排除无眼眶或附件疾病特征的眼科WG病例。
从问卷中获得的数据包括年龄、性别、局限性或全身性疾病、抗中性粒细胞胞浆抗体(ANCA)状态、症状和体征:鼻泪管阻塞、鼻窦炎、瘘管/眼眶骨质侵蚀、眼眶肿物/眼球突出、眼外肌/复视、视神经受压导致的视力下降、眼眶疼痛、眼睑水肿/红斑、活检情况及治疗情况。
确定并描述了29例眼眶及附件WG患者。症状包括感觉到眼眶肿物、溢泪、眼眶疼痛和复视。体征包括眼眶肿物或眼球突出(69%)、鼻泪管阻塞(52%)、眼球活动受限(52%)、眼睑红斑和水肿(31%)、骨质破坏(21%)以及视力下降(17%)。2例患者有持续性鼻泪管泪囊瘘管。52% 的患者存在胞浆型抗中性粒细胞胞浆抗体(c-ANCA),全身性疾病患者中有9例(共10例)呈阳性。然而,局限性WG患者中只有32%(19例中的6例)的c-ANCA呈阳性。10% 的病例核周型抗中性粒细胞胞浆抗体(p-ANCA)呈阳性。
为有效诊断和治疗眼科WG,临床医生必须了解其多样的眼眶及附件表现。WG可能伴有或不伴有全身受累,约半数病例c-ANCA呈阴性。我们的病例还出现了2例眼眶瘘管,此前认为这一情况较为罕见。